Advertisement
UK markets closed
  • FTSE 100

    8,275.38
    +44.33 (+0.54%)
     
  • FTSE 250

    20,730.12
    +59.25 (+0.29%)
     
  • AIM

    805.79
    +3.10 (+0.39%)
     
  • GBP/EUR

    1.1742
    -0.0007 (-0.06%)
     
  • GBP/USD

    1.2738
    +0.0006 (+0.05%)
     
  • Bitcoin GBP

    53,050.59
    -491.15 (-0.92%)
     
  • CMC Crypto 200

    1,421.26
    -7.31 (-0.51%)
     
  • S&P 500

    5,277.51
    +42.03 (+0.80%)
     
  • DOW

    38,686.32
    +574.84 (+1.51%)
     
  • CRUDE OIL

    77.18
    -0.73 (-0.94%)
     
  • GOLD FUTURES

    2,347.70
    -18.80 (-0.79%)
     
  • NIKKEI 225

    38,487.90
    +433.77 (+1.14%)
     
  • HANG SENG

    18,079.61
    -150.58 (-0.83%)
     
  • DAX

    18,497.94
    +1.15 (+0.01%)
     
  • CAC 40

    7,992.87
    +14.36 (+0.18%)
     

Rand Capital Invests $2.2 Million in Second Quarter of 2016

BUFFALO, NY--(Marketwired - August 02, 2016) -

  • Net Asset Value per share of $5.28 at quarter end

  • Added eHealth Global Technologies to portfolio with $1.5 million debt investment

  • Provided $0.7 million in loans as follow-on funding to support growth of five portfolio companies

  • Strong cash position with $14.4 million on hand; current priority to build investment income

Rand Capital Corporation (RAND) ("Rand"), a venture capital company that makes primarily equity investments in companies with emerging product, service or technology concepts, announced its results for the quarter ended June 30, 2016.

Allen F. ("Pete") Grum, President and Chief Executive Officer of Rand Capital, commented, "While we have a strong balance sheet and sufficient capital, we are currently prioritizing debt instrument investments to generate interest income. Our goal is to replace the income previously generated from investments exited in the trailing first quarter. All of the follow-on and initial investments we made in the second quarter were loans."

ADVERTISEMENT

He added, "We believe we have a straight-forward portfolio strategy:

  • Identify investments with strong growth potential to drive capital appreciation,

  • Balance the maturities of our investments to allow for staging of exits,

  • And, make investments that provide dividend or interest income to support operating costs.

Our pipeline of investment opportunities is strong. And, we believe that with this approach, we can repeat the levels of growth and success we have had over the last five and ten year periods."

Second Quarter Highlights

  • Reported $5.28 net asset value (NAV) per share at June 30, 2016, up $0.12 per share, or 2%, over June 30, 2015.

  • Invested $1.5 million in eHealth Global Technologies, Inc. during the quarter, a new addition to the Rand portfolio.

  • Supported existing portfolio companies with approximately $748,000 of loans during the quarter:

    • Empire Genomics, LLC: $250,000

    • SciAps, Inc.: $200,000

    • BeetNPath, LLC: $150,000

    • Genicon, Inc.: $100,000

    • Knoa Software, Inc.: $ 48,466

  • Made investments in the first half of 2016 that are expected to generate approximately $375,000 in annualized interest income.

  • Portfolio fair value was $27.7 million and cash was $14.4 million at the end of the 2016 second quarter.

Compared with the prior-year period, dividend and interest income was down $0.5 million in the second quarter of 2016. The decline was the result of the sale in the first quarter of Gemcor, a large dividend and interest generating asset. Additionally, operating expenses in the current quarter were up $104,723 compared with last year's second quarter, primarily due to higher professional fees related to evaluation of strategic options.

Selected portfolio highlights:

  • eHealth Global Technologies, Inc. (http://ehealthtechnologies.com/), a new investment this quarter, is an industry-leading provider of clinically-informed referral services. The company's eHealth Connect® solution enhances patient and physician satisfaction by intelligently aggregating patients' clinical records to streamline referrals. The company's eHealth Connect® Image Exchange enables automated access to full diagnostic quality medical images within the context of an aggregated patient record. Rand provided $1.5 million in a senior subordinated secured term loan.

  • SciAps, Inc. (http://sciaps.com/), is a leading provider of handheld analytical instruments used in industrial, service/security, and mining markets to identify and analyze compounds, minerals and elements. Rand provided a $200,000 subordinated convertible note in the second quarter, supporting the company's investments in new products and market penetration initiatives. This is the third follow-on since the initial investment in July 2013, and brings Rand's total investment in SciAps to approximately $2.45 million at June 30, 2016.

  • Tilson Technology Management, Inc. (http://www.tilsontech.com/). Another rapidly growing company within the Rand portfolio, Tilson is an information technology professional services and network construction company. Tilson recently announced that it was selected to manage the construction of security, communications and other elements for the final construction stages of a new US Embassy near Oslo, Norway. Tilson's headcount has approximately doubled in each of the past two years to support its growth initiatives. As of June 30, 2016, Rand's investment in Tilson was valued at $0.6 million in series B preferred shares issued in January 2015.

As of June 30, 2016, Rand's portfolio consisted of 31 active businesses. The portfolio is comprised of approximately 68% in equity investments and 32% in debt investments, compared with 77% in equity investments and 23% in debt investments at the same time last year.

Capital Allocation Priorities and Growth Strategy
Rand's priority for its capital is investment in its portfolio. However, the Company also maintains a share repurchase program which was authorized by the Board of Directors in October 2015. Under the program, the Company may repurchase up to approximately 465,000 shares through October 22, 2016. Rand will opportunistically use its capital to repurchase shares as a means of returning capital to shareholders.

Rand's growth strategy is to increase net asset value by capitalizing on maturing investments and leveraging those returns for further investment. Rand invests in companies at various stages of maturity with new or unique products or services that offer competitive advantage and compelling future potential.

ABOUT RAND CAPITAL
Rand Capital (RAND) provides investors the ability to participate in venture capital opportunities through an investment in the Company's stock. Rand is a Business Development Company (BDC), and its wholly-owned subsidiary is licensed by the U.S. Small Business Administration (SBA) as a Small Business Investment Company (SBIC). Rand focuses its equity investments in early or expansion stage companies and generally lends to more mature companies. Rand looks for strong leadership who is bringing to market new or unique products, technologies or services that have a high potential for growth. Additional information can be found at the Company's website where it regularly posts information: www.randcapital.com.

Safe Harbor Statement
This news release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements concerning future net asset value growth, investment returns and opportunities as well as Rand's plans for utilizing proceeds from sales of portfolio companies when and if received. These statements involve known and unknown risks, uncertainties and other factors that could cause the actual results to differ materially from the results expressed or implied by such statements, including general economic and business conditions, conditions affecting the portfolio companies' markets, competitor responses, and market acceptance of their products and services and other factors disclosed in the Corporation's periodic reports filed with the Securities and Exchange Commission. Consequently, such forward looking statements should be regarded as the Corporation's current plans, estimates and beliefs. The Corporation assumes no obligation to update the forward-looking information contained in this release.

FINANCIAL TABLES FOLLOW

Rand Capital Corporation and Subsidiary

Consolidated Statements of Financial Position

June 30,

2016

December 31,

(Unaudited)

2015

ASSETS

Investments at fair value:

Control investments (cost of $99,500 and $1,141,472, respectively)

$

1,512,000

$

13,916,472

Affiliate investments (cost of $16,708,952 and $17,663,217, respectively)

12,824,154

14,662,219

Non-Control/Non-affiliate investments (cost of $13,468,832 and $8,606,053, respectively).

13,321,933

8,253,709

Total investments, at fair value (cost of $30,277,284 and $27,410,742, respectively

27,658,087

36,832,400

Cash

14,376,673

5,844,795

Interest receivable (net of allowance: $122,000 at 6/30/16 and 12/31/15)

254,801

215,224

Deferred tax asset

633,086

-

Prepaid income taxes

-

65,228

Other assets

1,650,534

1,604,413

Total assets

$

44,573,181

$

44,562,060

LIABILITIES AND STOCKHOLDERS' EQUITY (NET ASSETS)

Liabilities:

Debentures guaranteed by the SBA (net of debt issuance costs)

$

7,814,073

$

7,800,373

Income tax payable

1,417,888

-

Deferred tax liability

-

2,361,186

Profit sharing and bonus payable

1,593,659

282,000

Accounts payable and accrued expenses

249,177

238,911

Deferred revenue

60,336

25,930

Total liabilities

11,135,133

10,708,400

Stockholders' equity (net assets):

Common stock, $.10 par; shares authorized 10,000,000; shares issued 6,863,034; shares outstanding of 6,328,538 as of 6/30/16 and 12/31/15

686,304

686,304

Capital in excess of par value

10,581,789

10,581,789

Accumulated net investment loss

(1,261,104

)

(24,580

)

Undistributed net realized gain on investments

26,629,373

18,262,401

Net unrealized (depreciation) appreciation on investments

(1,750,823

)

5,795,237

Treasury stock, at cost; 534,496 shares as of 6/30/16 and 12/31/15

(1,447,491

)

(1,447,491

)

Total stockholders' equity (net assets) (per share 6/30/16: $5.28, 12/31/15: $5.35)

33,438,048

33,853,660

Total liabilities and stockholders' equity

$

44,573,181

$

44,562,060

Rand Capital Corporation and Subsidiary

Consolidated Statements of Operations

(Unaudited)

For the Quarter Ended
June 30,

For the Six Months Ended June 30,

2016

2015

2016

2015

Investment income:

Interest from portfolio companies:

Control investments

$

-

$

20,275

$

11,828

$

42,420

Affiliate investments

94,614

96,522

159,575

211,651

Non-Control/Non-Affiliate investments

68,527

66,422

129,632

115,222

Total interest from portfolio companies

163,141

183,219

301,035

369,293

Interest from other investments:

Non-Control/Non-Affiliate investments

18,648

8,369

21,709

15,190

Total interest from other investments

18,648

8,369

21,709

15,190

Dividend and other investment income:

Control investments

-

491,208

-

903,359

Affiliate investments

33,232

29,061

80,797

58,429

Total dividend and other investment income

33,232

520,269

80,797

961,788

Fee income:

Control investments

-

2,000

2,000

4,000

Affiliate investments

1,167

416

1,862

1,833

Non-Control/Non-Affiliate investments

4,318

4,251

7,234

8,167

Total fee income

5,485

6,667

11,096

14,000

Total investment income

220,506

718,524

414,637

1,360,271

Operating expenses:

Salaries

155,437

149,555

310,875

299,110

Bonus and profit sharing

-

-

1,411,659

-

Employee benefits

36,711

29,394

126,222

59,801

Directors' fees

47,380

29,300

94,755

51,050

Professional fees

86,288

20,433

151,048

93,502

Stockholders and office operating

61,542

55,717

124,036

115,114

Insurance

6,258

6,300

17,518

17,554

Corporate development

16,055

14,400

31,525

31,381

Other operating

2,375

2,224

5,975

5,874

412,046

307,323

2,273,613

673,386

Interest on SBA obligations

77,570

77,569

155,139

151,891

Total operating expenses

489,616

384,892

2,428,752

825,277

Net investment (loss) income before income taxes

(269,110

)

333,632

(2,014,115

)

534,994

Income tax (benefit) expense

(114,564

)

101,920

(777,591

)

173,987

Net investment (loss) income

(154,546

)

231,712

(1,236,524

)

361,007

Net realized gain on investments:

Control investments

-

-

13,176,313

-

Non-Control/Non-Affiliate investments

168,140

131,181

168,140

262,925

Net realized gain before income taxes

168,140

131,181

13,344,453

262,925

Income tax expense

34,520

42,591

4,977,481

89,742

Net realized gain on investments

133,620

88,590

8,366,972

173,183

Net change in unrealized depreciation or appreciation on investments:

Control investments

-

-

(11,362,500

)

-

Affiliate investments

(325,000

)

(193,436

)

(747,800

)

(193,436

)

Non-Control/Non-Affiliate investments

69,444

(73,219

)

69,444

(127,728

)

Change in unrealized depreciation or appreciation before income taxes

(255,556

)

(266,655

)

(12,040,856

)

(321,164

)

Deferred income tax benefit

(78,390

)

(89,449

)

(4,494,796

)

(109,618

)

Net decrease in unrealized depreciation or appreciation on investments

(177,166

)

(177,206

)

(7,546,060

)

(211,546

)

Net realized and unrealized (loss) gain on investments

(43,546

)

(88,616

)

820,912

(38,363

)

Net (decrease) increase in net assets from operations

$

(198,092

)

$

143,096

$

(415,612

)

$

322,644

Weighted average shares outstanding

6,328,538

6,328,538

6,328,538

6,328,538

Basic and diluted net (decrease) increase in net assets from operations per share

$

(0.03

)

$

0.02

$

(0.07

)

$

0.05